Samsung Electronics Takes Step Into Korea's Biosimilar Foray With IND For MabThera Generic

SEOUL - South Korea's electronics and semiconductor giant Samsung Electronics has submitted an investigational new drug application to Korea FDA to conduct clinical trials for its biosimilar of Roche's MabThera.